Fluence Corporation Limited (EMFGF) Research

Fluence Corporation Limited specializes in delivering comprehensive water and wastewater treatment and reuse solutions for municipal, commercial, and industrial clients worldwide. The company's product offerings include cutting-edge desalination technologies like NIROBOX, which purifies seawater, brackish water, fresh water, and wastewater. They also provide the NIROFLEX series, featuring advanced desalination, ultrafiltration, multimedia filtration, and reverse osmosis systems. For wastewater management, Fluence supplies various products such as Aspiral, an innovative treatment solution; SUBRE membrane aerated biofilm reactor modules; EcoBox systems for water recycling; and Tipton packaged wastewater treatment plants. Furthermore, they offer aeration equipment, including aerators, mixers, and diffusers, alongside dissolved air flotation systems. Beyond water applications, Fluence extends its capabilities to food and beverage processing and recovery, as well as waste-to-energy solutions. Clients also benefit from essential support services, including project financing, the Smart Operations data analytics software, and comprehensive after-sale assistance. Incorporated in 2007, Fluence Corporation Limited is headquartered in White Plains, New York.

Open Fluence Corporation Limited (EMFGF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.